Mankind Pharma Limited (BOM:543904)
2,005.85
-34.40 (-1.69%)
At close: Mar 30, 2026
-17.22% (1Y)
| Market Cap | 828.05B -13.3% |
| Revenue (ttm) | 139.14B +19.5% |
| Net Income | 17.79B -12.8% |
| EPS | 43.10 -15.2% |
| Shares Out | n/a |
| PE Ratio | 46.54 |
| Forward PE | 35.69 |
| Dividend | 1.00 (0.05%) |
| Ex-Dividend Date | Aug 8, 2025 |
| Volume | 22,805 |
| Average Volume | 42,690 |
| Open | 2,030.15 |
| Previous Close | 2,040.25 |
| Day's Range | 1,988.55 - 2,030.15 |
| 52-Week Range | 1,909.90 - 2,726.75 |
| Beta | n/a |
| RSI | 42.23 |
| Earnings Date | May 22, 2026 |